[A patient with HCC successfully treated by ethanol injection therapy with etoposide].
A patient with hepatocellular carcinoma (HCC) who underwent successfully percutaneous ethanol injection therapy (PEIT) with etoposide was reported. A 72-year-old Japanese man with positive HCV-Ab developed multiple tumors of HCC. He underwent transcatheter arterial embolization (TAE) four times and PEIT three times, but the growth of tumors (particularly, S8) could not be controlled by these modalities. Then, the mixture of etoposide (20 mg), ethanol (8.5 ml) and lipiodol (1.5 ml) was injected into S6 tumors. Consistent with the normalization of serum AFP level, CT scan revealed the marked remaining lipiodol in these tumors. PEIT with etoposide is the treatment of choice in patients with HCC refractory to treatment by conventional TAE or PEIT.
Sakon
M
M
Dept. of Surgery II, Osaka University Medical School.
Kishimoto
S
S
Aoki
T
T
Okuyama
M
M
Shimizu
J
J
Yamada
T
T
Higaki
N
N
Taniguchi
K
K
Takeda
H
H
Sugimoto
K
K
Dohno
K
K
Osato
H
H
Umeshita
K
K
Gotoh
M
M
Monden
M
M
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage*; D005047:Etoposide / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male
D000431:Ethanol; D005047:Etoposide